[HTML][HTML] Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)

AI Adler, RJ Stevens, SE Manley, RW Bilous, CA Cull… - Kidney international, 2003 - Elsevier
Development and progression of nephropathy in type 2 diabetes: The United Kingdom
Prospective Diabetes Study (UKPDS 64). Background The progression of nephropathy from …

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney …

A Levin, PE Stevens, RW Bilous… - Kidney international …, 2013 - pure.johnshopkins.edu
The Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline
for the Evaluation and Management of Chronic Kidney Disease (CKD) serves to update the …

Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding?

B Vaidya, S Anthony, M Bilous, B Shields… - The Journal of …, 2007 - academic.oup.com
Context: Maternal subclinical hypothyroidism during pregnancy is associated with various
adverse outcomes. Recent consensus guidelines do not advocate universal thyroid function …

Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas

V Connolly, N Unwin, P Sherriff, R Bilous… - Journal of Epidemiology …, 2000 - jech.bmj.com
OBJECTIVE To establish the relation between socioeconomic status and the age-sex specific
prevalence of type 1 and type 2 diabetes mellitus. The hypothesis was that prevalence of …

[HTML][HTML] Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

…, M Maresh, G Kearney, J Morris, S Quinn, R Bilous… - The Lancet, 2017 - thelancet.com
Background Pregnant women with type 1 diabetes are a high-risk population who are
recommended to strive for optimal glucose control, but neonatal outcomes attributed to maternal …

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

…, R Klein, T Orchard, J Fuller, HH Parving, R Bilous… - The Lancet, 2008 - thelancet.com
Background Results of previous studies suggest that renin-angiotensin system blockers
might reduce the burden of diabetic retinopathy. We therefore designed the DIabetic …

[HTML][HTML] Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

…, M Porta, T Orchard, J Fuller, HH Parving, R Bilous… - The Lancet, 2008 - thelancet.com
Background Diabetic retinopathy remains a leading cause of visual loss in people of
working age. We examined whether candesartan treatment could slow the progression and, …

Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study

NA Roper, RW Bilous, WF Kelly, NC Unwin… - Bmj, 2001 - bmj.com
Objectives: To establish the age and sex specific mortality for people with diabetes in
comparison with local and national background populations; to investigate the relationship …

Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials

R Bilous, N Chaturvedi, AK Sjølie, J Fuller… - Annals of internal …, 2009 - acpjournals.org
Background: Microalbuminuria in diabetes is strongly predictive of nephropathy, end-stage
renal disease, and premature cardiovascular morbidity and mortality. Effective preventive …

[BOOK][B] Handbook of diabetes

R Bilous, R Donnelly, I Idris - 2021 - books.google.com
Rudy Bilous would like to dedicate this book firstly, to all of the people with diabetes for whom
he has had the privilege of caring in over 40 years of practice; and to his DSN partner and …